Table IV.
Multivariate Regression Models of 30 Day Predictors for: Total Bleeding, Major Bleeding, Minor Bleeding, MACCE, and NACE
| Odds Ratio | 95% Confidence Interval | |
|---|---|---|
| TOTAL BLEEDING: | ||
| Previous Percutaneous Coronary Intervention | 0.76 | 0.32 – 1.82 |
| Femoral Access | 1.79 | 0.58 – 5.46 |
| Radial Access | 0.55 | 0.18 – 1.70 |
| Bivalirudin | 1.49 | 0.62 – 3.55 |
| MAJOR BLEEDING: | ||
| Previous Percutaneous Coronary Intervention | 0.67 | 0.20 –2.30 |
| Femoral Access | 3.52 | 0.44 –28.20 |
| Bivalirudin | 2.32 | 0.60 – 9.02 |
| MINOR BLEEDING: | ||
| Previous Percutaneous Coronary Intervention | 1.05 | 0.40 – 2.74 |
| Femoral Access | 1.39 | 0.45 – 4.34 |
| Bivalirudin | 1.36 | 0.54 – 3.48 |
| MACCE: | ||
| Previous Percutaneous Coronary Intervention | 2.45 | 0.26 – 22.76 |
| Femoral Access | omitted* | |
| Bivalirudin | omitted* | |
| NACE: | ||
| Previous Percutaneous Coronary Intervention | 0.86 | 0.29 – 2.55 |
| Femoral Access | 4.92 | 0.63 – 38.54 |
| Bivalirudin | 3.65 | 1.00 – 13.36 |
*
Bivalirudin and access site were omitted from MACCE multivariate analyses as all events of MACCE at 30 days were among the bivalirudin group treated by femoral access